Cite
Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines
MLA
Beth-Ann G. Coller, et al. “Lessons Learned from the Development and Roll-Out of the RVSVΔG-ZEBOV-GP Zaire Ebolavirus Vaccine to Inform Marburg Virus and Sudan Ebolavirus Vaccines.” Vaccines, vol. 10, no. 9, Sept. 2022, p. 1446. EBSCOhost, https://doi.org/10.3390/vaccines10091446.
APA
Beth-Ann G. Coller, William Lapps, Mahum Yunus, Samantha Bruno, Michael J. Eichberg, Andrew Wen-Tseng Lee, Kenneth Liu, Rosybel Drury, Jules Millogo, Louis Robert Macareo, Thomas H. Armstrong, Jeffrey T. Blue, Lynne A. Isopi, Melissa Hughes, Susan M. VanRheenen, Jonathan Deutsch, Joan G. Tell, & Sheri A. Dubey. (2022). Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines. Vaccines, 10(9), 1446. https://doi.org/10.3390/vaccines10091446
Chicago
Beth-Ann G. Coller, William Lapps, Mahum Yunus, Samantha Bruno, Michael J. Eichberg, Andrew Wen-Tseng Lee, Kenneth Liu, et al. 2022. “Lessons Learned from the Development and Roll-Out of the RVSVΔG-ZEBOV-GP Zaire Ebolavirus Vaccine to Inform Marburg Virus and Sudan Ebolavirus Vaccines.” Vaccines 10 (9): 1446. doi:10.3390/vaccines10091446.